PL396319A1 - Preparat farmaceutyczny do leczenia zakazenia wirusem herpes simplex oraz zastosowanie - Google Patents
Preparat farmaceutyczny do leczenia zakazenia wirusem herpes simplex oraz zastosowanieInfo
- Publication number
- PL396319A1 PL396319A1 PL396319A PL39631911A PL396319A1 PL 396319 A1 PL396319 A1 PL 396319A1 PL 396319 A PL396319 A PL 396319A PL 39631911 A PL39631911 A PL 39631911A PL 396319 A1 PL396319 A1 PL 396319A1
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- formulation
- herpes simplex
- simplex virus
- virus infection
- Prior art date
Links
- 208000009889 Herpes Simplex Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 abstract 2
- 150000001450 anions Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000700584 Simplexvirus Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Preparat farmaceutyczny do leczenia zakażenia wirusem herpes simplex, w którym składnik aktywny stanowi zawiesina nanocząstek srebra o wielkości od 1 do 100 nm w wodnym roztworze zawierającym mieszaninę dopuszczalnych farmaceutycznie anionów co najmniej jednej soli kwasu organicznego i/lub anionów co najmniej jednej soli kwasu nieorganicznego, przy czym udział nanocząstek srebra w preparacie wynosi od 0,005 do 5% wag., udział roztworu wynosi od 0,005 do 5% obj., a udział nośnika od 95 do 99,995% obj.. Wynalazek dotyczy także zastosowania preparatu do wytwarzania leku do zapobiegania i leczenia zakażenia wirusem herpes simplex.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL396319A PL237937B1 (pl) | 2011-09-13 | 2011-09-13 | Preparat farmaceutyczny do leczenia zakażenia wirusem herpes simplex |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL396319A PL237937B1 (pl) | 2011-09-13 | 2011-09-13 | Preparat farmaceutyczny do leczenia zakażenia wirusem herpes simplex |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL396319A1 true PL396319A1 (pl) | 2013-03-18 |
| PL237937B1 PL237937B1 (pl) | 2021-06-14 |
Family
ID=47846451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL396319A PL237937B1 (pl) | 2011-09-13 | 2011-09-13 | Preparat farmaceutyczny do leczenia zakażenia wirusem herpes simplex |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL237937B1 (pl) |
-
2011
- 2011-09-13 PL PL396319A patent/PL237937B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL237937B1 (pl) | 2021-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015502628B1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
| MX2015016421A (es) | Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades. | |
| TR201904455T4 (tr) | Nükleer taşıma modülatörleri olarak 1,2,4-triazoller ve bunların kullanımları. | |
| EA201590371A1 (ru) | 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний | |
| GB2495676A (en) | Use of binders for manufacturing storage stable formulations | |
| TN2012000566A1 (en) | Dry powder formulation comprising an antimuscarinic drug | |
| UA112296C2 (uk) | Сухий порошковий препарат, який містить інгібітор фосфодіестерази | |
| PH12014501545A1 (en) | Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof | |
| MY180145A (en) | Cenicriviroc compositions and methods of making and using the same | |
| EP3069720A8 (en) | Pharmaceutical composition containing glutarimide derivatives, and application thereof for treating eosinophilic diseases | |
| MX2015016425A (es) | Derivados de pirazolo-pirrolidin-4-ona y su uso en el tratamiento de enfermedades. | |
| JP2013538853A5 (pl) | ||
| BR112014009242A8 (pt) | nanossuspensão farmacêutica | |
| WO2015100348A8 (en) | Keloid reduction using topical allantoin | |
| SI2729474T1 (en) | (TIENO (2,3-b) (1,5) BENZOXAZEPIN-4-YL) PIPERAZINE-1-IL COMPOUNDS AS TWO ACTIVE H1 INVERTIVE AGENTS / 5-HT2A ANTAGONISTS | |
| PL396319A1 (pl) | Preparat farmaceutyczny do leczenia zakazenia wirusem herpes simplex oraz zastosowanie | |
| MX2014015096A (es) | Alimento para crustaceos. | |
| TW201129660A (en) | Dermal absorption agent comprising felbinac | |
| EP2842938A4 (en) | NOVEL BETA-ALANINE DERIVATIVES, PHARMACEUTICALLY SALTS AND PHARMACEUTICAL COMPOSITION THEREFOR AS ACTIVE AGENT | |
| TR200802061A2 (tr) | Yüksek oranda aktif madde içeren farmasötlk formülasyon. | |
| WO2010027189A3 (ko) | 호모아이소플라베논 또는 이의 염의 신규한 용도 | |
| EA201500366A1 (ru) | Применение 1-адамантилетилокси-3-морфолино-2-пропанола или его фармацевтически приемлемых солей в фармацевтических композициях в качестве нейроретинопротектора | |
| UA80243U (ru) | Система доставки лекарств | |
| TH138424A (th) | สูตรผสมผงแห้งที่ประกอบรวมด้วยยาต้านมัสคารินิก |